Company Embecta Corp.

Equities

EMBC

US29082K1051

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-06-07 pm EDT 5-day change 1st Jan Change
12.44 USD -2.89% Intraday chart for Embecta Corp. +0.57% -34.28%

Business Summary

Embecta Corp. is a global medical device company. The Company is focused on providing solutions to people living with diabetes. The Company has a portfolio of products, including a range of pen needles, syringes and safety injection devices, which are complemented by its digital application designed to assist people with managing their diabetes. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. The Company also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. In addition to pen needles, it sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It distributes its products through a variety of channels, including retail, hospitals, pharmacies and other institutional channels.

Number of employees: 2,200

Sales per Business

USD in Million2022Weight2023Weight Delta
Diabetes Care
100.0 %
1,130 100.0 % 1,121 100.0 % -0.77%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
53.7 %
600 53.1 % 601 53.7 % +0.18%
International
46.3 %
529 46.9 % 519 46.3 % -1.85%

Managers

Managers TitleAgeSince
Chief Executive Officer 56 22-03-21
Director of Finance/CFO 51 22-03-21
Chief Tech/Sci/R&D Officer 60 21-09-30
Investor Relations Contact - 22-05-31
Sales & Marketing - 22-03-21
Human Resources Officer 66 23-06-30
General Counsel 52 22-03-21
Comptroller/Controller/Auditor 50 22-03-31
Corporate Officer/Principal 55 22-03-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 68 22-03-31
Director/Board Member 60 22-03-31
Director/Board Member 58 22-03-19
Chairman 70 22-03-31
Director/Board Member 54 22-03-31
Director/Board Member 58 22-03-31
Director/Board Member 69 22-03-31
Chief Executive Officer 56 22-03-21
Director/Board Member 56 22-03-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 57,670,209 57,401,997 ( 99.53 %) 0 99.53 %

Shareholders

NameEquities%Valuation
BlackRock Advisors LLC
15.33 %
8,826,797 15.33 % 92 M $
Vanguard Fiduciary Trust Co.
12.53 %
7,213,992 12.53 % 75 M $
River Road Asset Management LLC
5.986 %
3,446,886 5.986 % 36 M $
Millennium Management LLC
5.617 %
3,234,231 5.617 % 34 M $
American Century Cos., Inc.
5.461 %
3,144,140 5.461 % 33 M $
Yacktman Asset Management LP
4.891 %
2,816,428 4.891 % 29 M $
Deerfield Management Co. LP (Private Equity)
4.735 %
2,726,135 4.735 % 28 M $
2,520,078 4.377 % 26 M $
Fidelity Management & Research Co. LLC
4.176 %
2,404,404 4.176 % 25 M $
Charles Schwab Investment Management, Inc.
2.304 %
1,326,604 2.304 % 14 M $

Company contact information

Embecta Corp.

300 Kimball Drive Suite 300

07417-07054, Parsippany

+862 401 0000

http://www.embecta.com
address Embecta Corp.(EMBC)